Portage Biotech Inc Capital Reinvestment Ratio

Latest as of June 2013: 0.02x

Portage Biotech Inc capital reinvestment ratio. Portage Biotech Inc (PRTG) has a Capital Reinvestment Ratio of 0.02x as of June 2013, meaning it reinvests 0% of its operating cash flow ($217.91K) in capital expenditures ($5.30K). Check how aggressively does Portage Biotech Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$217.91K

USD

Capital Expenditures

$5.30K

USD

Data as of

Jun 2013

Most recent filing

Portage Biotech Inc Capital Reinvestment Ratio by Year (None–None)

Portage Biotech Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see PRTG operating cash flow.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow